Spinal cord stimulators: 3 years of advances
By Admin | March 30, 2025
Spinal cord stimulators have grown in popularity over the past several years as patients see benefits in the less-invasive procedure.
Stimulators help patients to treat chronic pain without invasive spine or back surgery, and they can treat a wide range of pain types, as well as pain from different types of conditions or sources.
They can also replace other forms of pain management, such as opioids, which can be addictive.
Here is a timeline of how spinal cord stimulators have advanced in the U.S. since 2023:
2023
January: A long-term study of Saluda Medical’s Evoke spinal cord stimulator found most patients had significant pain reduction and no explants.
February: Therapy development company Aneuvo launched a clinical trial for its ExaStim TSS system, a wirelessly controlled, noninvasive spinal cord stimulator. The ExaStim neurostimulator received FDA breakthrough device designation status.
May: Spinal cord stimulator use was expanded when National Surgical Center Stockton (Calif.) began offering HFX, high-frequency spinal cord stimulation procedures for the treatment of diabetic neuropathy.
Abbott’s spinal cord stimulation devices earned FDA approval to address chronic back pain for patients who aren’t...(More)
For more info please read, Spinal cord stimulators: 3 years of advances, by Becker's Spine Review
